-
Maternal Serum Placental Growth Factor (PlGF) Isoforms 1 and 2 at 11-13 Weeks' Gestation in Normal and Pathological Pregnancies.
Nucci M, Poon LC, Demirdjian G, Darbouret B, Nicolaides KH.
Fetal Diagn Ther 2014;36:106-16.. pdf -
Maternal age and adverse pregnancy outcomes: a cohort study.
Khalil A, Syngelaki A, Maiz N, Zinevich Y, Nicolaides KH.
Ultrasound Obstet Gynecol 2013;42:634-43. pdf -
Maternal serum retinol-binding protein-4 at 11-13weeks' gestation in normal and pathological pregnancies.
Nanda S, Nikoletakis G, Markova D, Poon LC, Nicolaides KH.
Metabolism 2013;62:814-9. -
Maternal serum resistin at 11 to 13 weeks' gestation in normal and pathological pregnancies.
Nanda S, Poon LC, Muhaisen M, Acosta IC, Nicolaides KH.
Metabolism 2012;61:699-705. -
Quantitative ELISAs for serum soluble LHCGR and hCG-LHCGR complex: potential diagnostics in first trimester pregnancy screening for stillbirth, down's syndrome, preterm delivery and preeclampsia.
Chambers AE, Griffin C, Naif SA, Mills I, Mills WE, Syngelaki A, Nicolaides KH, Banerjee S.
Reprod Biol Endocrinol 2012;10:113. -
First-trimester uterine artery Doppler and serum pregnancy-associated plasma protein-a in preeclampsia and chromosomal defects.
Staboulidou I, Galindo A, Maiz N, Karagiannis G, Nicolaides KH.
Fetal Diagn Ther 2009;25:336-9. -
Some thoughts on the true value of ultrasound.
Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:671-4. -
Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: a case-control study and a meta-analysis.
Yu CKh, Casas JP, Savvidou MD, Sahemey MK, Nicolaides KH, Hingorani AD.
BMC Pregnancy Childbirth 2006;6:7. -
Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: theoretical and empirical considerations.
Tong YK, Ding C, Chiu RW, Gerovassili A, Chim SS, Leung TY, Leung TN, Lau TK, Nicolaides KH, Lo YM.
Clin Chem 2006;52:2194-202. -
Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation.
Spencer K, Yu CK, Savvidou M, Papageorghiou AT, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;27:658-63. -
Frontomaxillary facial angle at 11 + 0 to 13 + 6 weeks' gestation-reproducibility of measurements.
Plasencia W, Dagklis T, Sotiriadis A, Borenstein M, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;29:18-21. -
A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound.
Nicolaides KH, Bindra R, Turan OM, Chefetz I, Sammar M, Meiri H, Tal J, Cuckle HS.
Ultrasound Obstet Gynecol 2006;27:13-7. -
Cystic hygromas, nuchal edema, and nuchal translucency at 11-14 weeks of gestation.
Molina FS, Avgidou K, Kagan KO, Poggi S, Nicolaides KH.
Obstet Gynecol 2006;107:678-83. -
Can aneroid sphygmomanometers be used at altitude?
Kametas NA, McAuliffe F, Krampl E, Nicolaides KH, Shennan AH.
J Hum Hypertens 2006;20:517-22. -
Relation between increased fetal nuchal translucency thickness and chromosomal defects.
Kagan KO, Avgidou K, Molina FS, Gajewska K, Nicolaides KH.
Obstet Gynecol 2006;107:6-10. -
Fetal tricuspid regurgitation at the 11 + 0 to 13 + 6-week scan: association with chromosomal defects and reproducibility of the method.
Falcon O, Faiola S, Huggon I, Allan L, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;27:609-12. -
Three-dimensional evaluation of mid-facial hypoplasia in fetuses with trisomy 21 at 11 + 0 to 13 + 6 weeks of gestation.
Dagklis T, Borenstein M, Peralta CF, Faro C, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;28:261-5. -
Fetal nuchal translucency scan and early prenatal diagnosis of chromosomal abnormalities by rapid aneuploidy screening: observational study.
Chitty LS, Kagan KO, Molina FS, Waters JJ, Nicolaides KH.
BMJ 2006;332:452-5. -
Aneuploidy screening in a coelomic sample from a missed abortion using sequential fluorescence in situ hybridization.
Chatzimeletiou K, Makrydimas G, Nicolaides KH.
Fertil Steril 2006;85:1059. -
Hypermethylated RASSF1A in Maternal Plasma: A Universal Fetal DNA Marker that Improves the Reliability of Noninvasive Prenatal Diagnosis.
Chan KC, Ding C, Gerovassili A, Yeung SW, Chiu RW, Leung TN, Lau TK, Chim SS, Chung GT, Nicolaides KH, Lo YM.
Clin Chem 2006;52:2211-8.